Financial Survey: OMNOVA Solutions (OMN) versus Its Rivals

OMNOVA Solutions (NYSE: OMN) is one of 52 public companies in the “Specialty Chemicals” industry, but how does it compare to its peers? We will compare OMNOVA Solutions to related businesses based on the strength of its profitability, institutional ownership, dividends, risk, valuation, analyst recommendations and earnings.

Institutional & Insider Ownership

88.0% of OMNOVA Solutions shares are held by institutional investors. Comparatively, 69.9% of shares of all “Specialty Chemicals” companies are held by institutional investors. 4.8% of OMNOVA Solutions shares are held by insiders. Comparatively, 7.1% of shares of all “Specialty Chemicals” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

This article was originally published by and is the sole property of Zolmax. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://zolmax.com/investing/financial-survey-omnova-solutions-omn-versus-its-rivals/1654494.html

Volatility and Risk

OMNOVA Solutions has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, OMNOVA Solutions’ peers have a beta of 1.58, indicating that their average share price is 58% more volatile than the S&P 500.

Profitability

This table compares OMNOVA Solutions and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OMNOVA Solutions -1.19% 18.52% 2.97%
OMNOVA Solutions Competitors -2.31% 9.09% 4.11%

Analyst Ratings

This is a summary of recent ratings for OMNOVA Solutions and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMNOVA Solutions 0 1 2 0 2.67
OMNOVA Solutions Competitors 255 1204 1318 33 2.40

OMNOVA Solutions presently has a consensus price target of $12.00, indicating a potential upside of 31.87%. As a group, “Specialty Chemicals” companies have a potential upside of 3.34%. Given OMNOVA Solutions’ stronger consensus rating and higher probable upside, analysts plainly believe OMNOVA Solutions is more favorable than its peers.

Valuation & Earnings

This table compares OMNOVA Solutions and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
OMNOVA Solutions $778.50 million $82.20 million -43.33
OMNOVA Solutions Competitors $1.95 billion $301.80 million 16.62

OMNOVA Solutions’ peers have higher revenue and earnings than OMNOVA Solutions. OMNOVA Solutions is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

OMNOVA Solutions beats its peers on 8 of the 13 factors compared.

About OMNOVA Solutions

OMNOVA Solutions Inc. is a provider of emulsion polymers, specialty chemicals and engineered surfaces for commercial, industrial and residential end uses. The Company’s segments include Performance Chemicals and Engineered Surfaces. The Performance Chemicals segment produces a range of emulsion polymers and specialty chemicals based on styrene butadiene, styrene butadiene acrylonitrile, styrene butadiene vinyl pyridine, nitrile butadiene, polyvinyl acetate, acrylic, styrene acrylic, vinyl acrylic, glyoxal, fluorochemical and bio-based chemistries. The Engineered Surfaces segment develops, designs, produces and markets a line of functional and decorative surfacing products, including coated fabrics, vinyl, paper, and specialty laminates and industrial films. The Performance Chemicals segment includes two product lines: Performance Materials and Specialty Chemicals, and the Engineered Surfaces segment includes two product lines: Coated Fabrics, and Laminates and Performance Films.

Receive News & Ratings for OMNOVA Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OMNOVA Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Bco Com Portugues  Given Consensus Rating of “Sell” by Analysts
Bco Com Portugues Given Consensus Rating of “Sell” by Analysts
GSA Capital Partners LLP Invests $258,000 in Aerie Pharmaceuticals, Inc.  Stock
GSA Capital Partners LLP Invests $258,000 in Aerie Pharmaceuticals, Inc. Stock
Crestwood Equity Partners LP  Shares Sold by GSA Capital Partners LLP
Crestwood Equity Partners LP Shares Sold by GSA Capital Partners LLP
GSA Capital Partners LLP Invests $270,000 in Sabra Healthcare REIT, Inc.  Stock
GSA Capital Partners LLP Invests $270,000 in Sabra Healthcare REIT, Inc. Stock
Citigroup Inc. Buys 897 Shares of WisdomTree Internationl Dvdnd Ex Fncl Fd
Citigroup Inc. Buys 897 Shares of WisdomTree Internationl Dvdnd Ex Fncl Fd
First Bancorp  Shares Sold by GSA Capital Partners LLP
First Bancorp Shares Sold by GSA Capital Partners LLP


Leave a Reply

 
© 2006-2017 Zolmax.